Purchase Order HHSN272201600703P
Award Date 5/25/16
Potential Completion Date 6/1/16
Potential Value $4.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents. The $129,931.28 contract is for the purchase of Illumina's MiSeq Reagent Kit V3, a sequencing consumable, without any set-aside designation. Illumina has previously received other prime federal contracts and sub-awards from agencies like the CDC,...
- This is a firm fixed price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the prime contractor Illumina, Inc. for the purchase of MiSeq sequencing kits. The order, valued at $13,071, does not have a set-aside designation. Illumina is a for-profit manufacturer and provider of genetic sequencing and analysis instruments and reagents. The award supports NIAID's genomic research and diagnostics...
- This is a $119,060.18 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc. for the provision of an MISEQ2 sequencing instrument and associated reagents. The contract has no set-aside designation. Illumina, a manufacturer of genetic analysis instruments and reagents, has been awarded multiple prior federal contracts and sub-grants to provide...
- This is a firm fixed price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The order is for the procurement of a MiSeq Reagent Kit V3 (600 cycle) with a ceiling value of $38,877.12. There was no set-aside used for this award. Illumina has received numerous prior prime contract awards from federal agencies like NIH, CDC,...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $4,638.33 contract is for Illumina reagent kits to support the agency's research and diagnostic needs. Illumina has a history of providing sequencing systems, reagents, and bioinformatics products to federal agencies like the CDC,...
- The Department of Health and Human Services' National Institutes of Health awarded a $4,570.01 firm fixed price delivery order contract to Illumina, Inc., a for-profit manufacturer of genetic sequencing systems and reagents, for the provision of Illumina MiSeq sequencing kits. The contract has no set-aside designation and was awarded on July 28, 2017, with a completion date of August 7, 2017. Illumina has a history of providing sequencing instruments, consumables, and services to support genomic...
- This is a $15,395.83 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for TruSeq reagent kits. The award has no set-aside designation. Illumina is a manufacturer of sequencing and genomic analysis instruments and reagents, and has previously received prime contracts and subcontracts from federal agencies like NIH, CDC, USDA, and VA to provide a range of sequencing...
- This is a firm fixed-price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract, valued at $91,472.77, is for the provision of reagents and consumables to support Illumina's sequencing platforms, including NextSeq, NovaSeq, MiSeq, and iSeq systems. This appears to be a standing purchase order without a...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The contract, valued at $4,037.50, is for the delivery of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, and support services. The contract has no set-aside designation....
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price delivery order to Illumina, Inc., a for-profit manufacturer of genomic sequencing systems and reagents, for the provision of MiSeq Reagent Kits V3 (600 cycle). The potential value of this award is $14,694.94. Illumina has previously been awarded prime contracts and subcontracts by various federal agencies, including the NIH, CDC, USDA, and VA,...